These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38693750)

  • 21. More Frequent Surveillance Following Lung Cancer Resection Is Not Associated With Improved Survival: A Nationally Representative Cohort Study.
    McMurry TL; Stukenborg GJ; Kessler LG; Colditz GA; Wong ML; Francescatti AB; Jones DR; Schumacher JR; Greenberg CC; Chang GJ; Winchester DP; McKellar DP; Kozower BD
    Ann Surg; 2018 Oct; 268(4):632-639. PubMed ID: 30004919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgery after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer: why pneumonectomy should be avoided.
    Kappers I; van Sandick JW; Burgers SA; Belderbos JS; van Zandwijk N; Klomp HM
    Lung Cancer; 2010 May; 68(2):222-7. PubMed ID: 19664843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Sekihara K; Hishida T; Yoshida J; Oki T; Omori T; Katsumata S; Ueda T; Miyoshi T; Goto M; Nakasone S; Ichikawa T; Matsuzawa R; Aokage K; Goto K; Tsuboi M
    Eur J Cardiothorac Surg; 2017 Sep; 52(3):522-528. PubMed ID: 28482033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase II study to assess the effect of adjuvant immunotherapy using α-GalCer-pulsed dendritic cells in the patients with completely resected stage II-IIIA non-small cell lung cancer: study protocol for a randomized controlled trial.
    Saka H; Kitagawa C; Ichinose Y; Takenoyama M; Ibata H; Kato T; Takami K; Yamashita M; Maeda T; Takeo S; Ueda H; Okabayashi K; Nagashima S; Oka T; Kouso H; Fukuyama S; Yoshimoto K; Shimokawa M; Saito AM; Ito S
    Trials; 2017 Sep; 18(1):429. PubMed ID: 28915900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer.
    Crabtree TD; Denlinger CE; Meyers BF; El Naqa I; Zoole J; Krupnick AS; Kreisel D; Patterson GA; Bradley JD
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):377-86. PubMed ID: 20400121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer.
    Gómez-Caro A; Boada M; Cabañas M; Sanchez M; Arguis P; Lomeña F; Ramirez J; Molins L
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):93-100; discussion 100. PubMed ID: 22290911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer.
    Westeel V; Choma D; Clément F; Woronoff-Lemsi MC; Pugin JF; Dubiez A; Depierre A
    Ann Thorac Surg; 2000 Oct; 70(4):1185-90. PubMed ID: 11081867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited resection for clinical Stage IA non-small-cell lung cancers based on a standardized-uptake value index.
    Shiono S; Abiko M; Sato T
    Eur J Cardiothorac Surg; 2013 Jan; 43(1):e7-e12. PubMed ID: 23129358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer.
    Martini N; Rusch VW; Bains MS; Kris MG; Downey RJ; Flehinger BJ; Ginsberg RJ
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):32-6; discussion 37-8. PubMed ID: 9869756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of surgery in N2 NSCLC: pros.
    Shien K; Toyooka S
    Jpn J Clin Oncol; 2016 Dec; 46(12):1168-1173. PubMed ID: 27655902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of low-dose spiral CT of the chest in regular follow-up of postoperative non-small cell lung cancer patients: Preliminary report.
    Chiu CH; Chern MS; Wu MH; Hsu WH; Wu YC; Huang MH; Chang SC
    J Thorac Cardiovasc Surg; 2003 Jun; 125(6):1300-5. PubMed ID: 12830048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastasis.
    Yoshino I; Nakanishi R; Osaki T; Hasuda S; Taga S; Takenoyama M; Yoshimatsu T; Yasumoto K
    Ann Thorac Surg; 1997 Sep; 64(3):809-13. PubMed ID: 9307478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L).
    Nakamura K; Saji H; Nakajima R; Okada M; Asamura H; Shibata T; Nakamura S; Tada H; Tsuboi M
    Jpn J Clin Oncol; 2010 Mar; 40(3):271-4. PubMed ID: 19933688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up.
    Billè A; Ahmad U; Woo KM; Suzuki K; Adusumilli P; Huang J; Jones DR; Rizk NP
    Ann Thorac Surg; 2016 Oct; 102(4):1067-73. PubMed ID: 27345095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial.
    Lee JM; Vallières E; Ding B; Johnson A; Bhagwakar J; Rashidi S; Zhu QC; Gitlitz BJ; Weksler B; Costas K; Altorki N
    J Thorac Cardiovasc Surg; 2023 Sep; 166(3):655-666.e7. PubMed ID: 36841745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic significance of clinical/pathological stage IA non-small-cell lung cancer showing partially solid or solid tumours on radiological exam.
    Uehara H; Matsuura Y; Nakao M; Mun M; Nakagawa K; Ishikawa Y; Okumura S
    Ann Thorac Cardiovasc Surg; 2015; 21(4):338-44. PubMed ID: 25740451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of local recurrence of lung cancer and possibilities for surgical management.
    Stojiljkovic D; Mandaric D; Miletic N; Stojsic J; Markovic I; Gavrilovic D; Pupic G; Stojiljkovic T; Lukac B; Dzodic R
    J BUON; 2013; 18(1):169-75. PubMed ID: 23613403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
    Saji H; Okada M; Tsuboi M; Nakajima R; Suzuki K; Aokage K; Aoki T; Okami J; Yoshino I; Ito H; Okumura N; Yamaguchi M; Ikeda N; Wakabayashi M; Nakamura K; Fukuda H; Nakamura S; Mitsudomi T; Watanabe SI; Asamura H;
    Lancet; 2022 Apr; 399(10335):1607-1617. PubMed ID: 35461558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local recurrence after surgery for non-small cell lung cancer: a recursive partitioning analysis of multi-institutional data.
    Kelsey CR; Higgins KA; Peterson BL; Chino JP; Marks LB; D'Amico TA; Varlotto JM
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):768-773.e1. PubMed ID: 23856204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.